The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Research Report 2025
Synopsis
Percutaneous transluminal coronary angioplasty (PTCA) is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle.
The global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Percutaneous Transluminal Coronary Angioplasty (PTCA) Products include Boston Scientific, Abbott, Medtronic, Cardinal Health, Asahi Intecc, Terumo, MicroPort, Lepu Medical and Biosensors International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Percutaneous Transluminal Coronary Angioplasty (PTCA) Products.
Report Scope
The Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific
Abbott
Medtronic
Cardinal Health
Asahi Intecc
Terumo
MicroPort
Lepu Medical
Biosensors International
Philips
Yinyi
Wellinq
Teleflex
Sinomed
Segment by Type
PTCA Balloon
PTCA Guide
Segment by Application
Hospitals and Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Percutaneous Transluminal Coronary Angioplasty (PTCA) Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Percutaneous transluminal coronary angioplasty (PTCA) is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle.
The global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Percutaneous Transluminal Coronary Angioplasty (PTCA) Products include Boston Scientific, Abbott, Medtronic, Cardinal Health, Asahi Intecc, Terumo, MicroPort, Lepu Medical and Biosensors International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Percutaneous Transluminal Coronary Angioplasty (PTCA) Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Percutaneous Transluminal Coronary Angioplasty (PTCA) Products.
Report Scope
The Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific
Abbott
Medtronic
Cardinal Health
Asahi Intecc
Terumo
MicroPort
Lepu Medical
Biosensors International
Philips
Yinyi
Wellinq
Teleflex
Sinomed
Segment by Type
PTCA Balloon
PTCA Guide
Segment by Application
Hospitals and Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Percutaneous Transluminal Coronary Angioplasty (PTCA) Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PTCA Balloon
1.2.3 PTCA Guide
1.3 Market by Application
1.3.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Perspective (2019-2030)
2.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Growth Trends by Region
2.2.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Historic Market Size by Region (2019-2024)
2.2.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Region (2025-2030)
2.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Dynamics
2.3.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Industry Trends
2.3.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Drivers
2.3.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Challenges
2.3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players by Revenue
3.1.1 Global Top Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Players by Revenue (2019-2024)
3.1.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue Market Share by Players (2019-2024)
3.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue
3.4 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Concentration Ratio
3.4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Revenue in 2023
3.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Key Players Head office and Area Served
3.6 Key Players Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Product Solution and Service
3.7 Date of Enter into Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Breakdown Data by Type
4.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Historic Market Size by Type (2019-2024)
4.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Type (2025-2030)
5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Breakdown Data by Application
5.1 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Historic Market Size by Application (2019-2024)
5.2 Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2019-2030)
6.2 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2019-2024)
6.4 North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2019-2030)
7.2 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2019-2024)
7.4 Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2019-2030)
8.2 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Region (2019-2024)
8.4 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2019-2030)
9.2 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2019-2024)
9.4 Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size (2019-2030)
10.2 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2019-2024)
10.4 Middle East & Africa Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Detail
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.1.4 Boston Scientific Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.1.5 Boston Scientific Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.2.4 Abbott Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Detail
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.3.4 Medtronic Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.3.5 Medtronic Recent Development
11.4 Cardinal Health
11.4.1 Cardinal Health Company Detail
11.4.2 Cardinal Health Business Overview
11.4.3 Cardinal Health Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.4.4 Cardinal Health Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.4.5 Cardinal Health Recent Development
11.5 Asahi Intecc
11.5.1 Asahi Intecc Company Detail
11.5.2 Asahi Intecc Business Overview
11.5.3 Asahi Intecc Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.5.4 Asahi Intecc Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.5.5 Asahi Intecc Recent Development
11.6 Terumo
11.6.1 Terumo Company Detail
11.6.2 Terumo Business Overview
11.6.3 Terumo Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.6.4 Terumo Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.6.5 Terumo Recent Development
11.7 MicroPort
11.7.1 MicroPort Company Detail
11.7.2 MicroPort Business Overview
11.7.3 MicroPort Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.7.4 MicroPort Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.7.5 MicroPort Recent Development
11.8 Lepu Medical
11.8.1 Lepu Medical Company Detail
11.8.2 Lepu Medical Business Overview
11.8.3 Lepu Medical Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.8.4 Lepu Medical Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.8.5 Lepu Medical Recent Development
11.9 Biosensors International
11.9.1 Biosensors International Company Detail
11.9.2 Biosensors International Business Overview
11.9.3 Biosensors International Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.9.4 Biosensors International Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.9.5 Biosensors International Recent Development
11.10 Philips
11.10.1 Philips Company Detail
11.10.2 Philips Business Overview
11.10.3 Philips Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.10.4 Philips Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.10.5 Philips Recent Development
11.11 Yinyi
11.11.1 Yinyi Company Detail
11.11.2 Yinyi Business Overview
11.11.3 Yinyi Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.11.4 Yinyi Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.11.5 Yinyi Recent Development
11.12 Wellinq
11.12.1 Wellinq Company Detail
11.12.2 Wellinq Business Overview
11.12.3 Wellinq Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.12.4 Wellinq Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.12.5 Wellinq Recent Development
11.13 Teleflex
11.13.1 Teleflex Company Detail
11.13.2 Teleflex Business Overview
11.13.3 Teleflex Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.13.4 Teleflex Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.13.5 Teleflex Recent Development
11.14 Sinomed
11.14.1 Sinomed Company Detail
11.14.2 Sinomed Business Overview
11.14.3 Sinomed Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Introduction
11.14.4 Sinomed Revenue in Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Business (2019-2024)
11.14.5 Sinomed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
